Results 201 to 210 of about 143,744 (251)
Deciphering genetic susceptibility to clear cell renal cell carcinoma. [PDF]
Mandelia M +5 more
europepmc +1 more source
c‐Met‐Targeted Imaging Agents: Progress and Challenges
This review summarizes recent advances in c‐Met‐targeted imaging probes, including hepatocyte growth factor (HGF) ligands, antibodies, peptides, and small molecules across magnetic resonance imaging (MRI), positron emission tomography (PET), single‐photon emission computed tomography (SPECT), and optical imaging modalities.
Yonghao Li +4 more
wiley +1 more source
Correction: MRI-based habitat radiomics for predicting WHO/ISUP nuclear grade in clear cell renal cell carcinoma. [PDF]
Shi N, Zhang C, Li X, Hao M, Liu C.
europepmc +1 more source
ABSTRACT Aristolochia species have long been used in traditional medicine for their presumed anti‐inflammatory, analgesic and antimicrobial properties. However, extensive toxicological and epidemiological evidence now demonstrates that these plants contain aristolochic acids (AAs) I and II, highly potent nephrotoxic, genotoxic, and carcinogenic ...
Victor Ventura de Souza +2 more
wiley +1 more source
Comprehensive analysis of ATF3 as a diagnostic and prognostic biomarker from pan-cancer to clear cell renal cell carcinoma. [PDF]
Ling H, Wu G, Hu Y.
europepmc +1 more source
ABSTRACT Oxaliplatin is a platinum‐based anticancer agent widely used for gastrointestinal malignancies; however, it is known to cause dose‐dependent peripheral neuropathy (OIPN), a characteristic adverse effect. OIPN results in a reduced quality of life and often necessitates dose reduction or discontinuation of oxaliplatin; however, effective ...
Yusuke Koura +11 more
wiley +1 more source
Epigenomic subtypes and prognostic methylation signatures in clear cell renal cell carcinoma. [PDF]
Iisager L +11 more
europepmc +1 more source
A pathomics-based pyroptosis signature predicts survival in clear cell renal cell carcinoma. [PDF]
Wang K +7 more
europepmc +1 more source

